|

AI-Based Stool Image Analysis for Colorectal Neoplasia Risk Assessment

RECRUITINGSponsored by Servicio de Salud Metropolitano Sur Oriente
Actively Recruiting
SponsorServicio de Salud Metropolitano Sur Oriente
Started2026-05-08
Est. completion2026-12
Eligibility
Age18 Years+

Summary

This prospective observational substudy evaluates the association between artificial intelligence-derived features from stool images analyzed using the FAEX Health digital platform and fecal immunochemical test results in adults undergoing colorectal cancer screening or diagnostic evaluation. Participants will capture stool images using a mobile application. The primary analysis will compare AI-derived image outputs with quantitative FIT values and FIT positivity. Secondary exploratory analyses will assess associations with colonoscopy and histopathological findings when these results are available. The platform will be used exclusively for research and will not provide diagnoses, replace clinical evaluation, or influence medical decisions.

Eligibility

Age: 18 Years+
Inclusion Criteria:

* Age 18 years or older.
* Referred for screening or diagnostic colonoscopy at Hospital Dr. Sótero del Río.
* Quantitative fecal immunochemical testing planned or completed within 30 days before or after stool image submission.
* Able to submit at least one stool image using the FAEX Health mobile application, independently or with assistance.
* Able and willing to provide written informed consent.

Exclusion Criteria:

* Unable or unwilling to provide written informed consent.
* Previous enrollment in the study.
* Unable to complete stool-image capture, even with assistance.
* Study images and clinical data cannot be reliably linked using the assigned study code.

Conditions2

CancerColorectal Neoplasms

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.